DJIA 18,024.06 183.54 1.03%
NASDAQ 5,005.39 63.97 1.29%
S&P 500 2,108.29 22.78 1.09%
market minute promo

Seattle Genetics (NASDAQ: SGEN)

34.03 -0.31 (-0.90%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SGEN $34.03 -0.90%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $34.10
Previous Close $34.34
Daily Range $32.68 - $35.45
52-Week Range $30.05 - $44.95
Market Cap $4.2B
P/E Ratio -55.39
Dividend (Yield) $0.00 (0.0%)
Volume 1,850,090
Average Daily Volume 987,234
Current FY EPS -$0.71

Sector

Healthcare

Industry

Drug Makers

Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website: http://www.seattlegenetics.com/

News & Commentary Rss Feed

Seattle Genetics, Inc. Posts Solid First-Quarter Revenue, Raises Expense Guidance

Not exactly the beat-and-raise investors were looking for.

Seattle Genetics' (SGEN) CEO Clay Siegall on Q1 2015 Results - Earnings Call Transcript

3 Things to Watch as Seattle Genetics, Inc. Reports Earnings

Adcetris sales, potential label expansion, and an update on the pipeline will all be important.

Today's Water-Logged And Getting Wetter Stock: Seattle Genetics (SGEN)

First Week of December 18th Options Trading For Seattle Genetics

Seattle Genetics (SGEN) is the 'Chart of the Day'

Seattle Genetics' Adcetris Under Review for New Indication - Analyst Blog

Seattle Genetics' Adcetris Under Review for New Indication - Analyst Blog

Notable Two Hundred Day Moving Average Cross - SGEN

Johnson & Johnson's Earnings: The Good, The Bad and The Ugly

Johnson & Johnson reported a mixed first-quarter this week. Here is what investors need to know going forward.

SGEN Crosses Below Key Moving Average Level

See More SGEN News...

SGEN's Top Competitors

SGEN $34.03 (-0.90%)
Current stock: SGEN
AMGN $160.36 (1.55%)
Current stock: AMGN
GILD $105.01 (4.48%)
Current stock: GILD
BIIB $386.22 (3.29%)
Current stock: BIIB